That is indicated by the Epi-Phare scientific group, depending on the French public administration.
This Monday it was revealed in a French examine that the Pfizer-BioNTech coronavirus vaccine doesn’t enhance the chance of great cardiovascular issues comparable to coronary heart assaults, strokes or pulmonary embolisms in these over 75 years of age.
Vaccination with this drug “doesn’t look like related to an elevated danger of great cardiovascular occasions in individuals aged 75 years or older”, each after the primary and after the second dose, conclude the authors of the examine carried out by the scientific group Epi -Phare, depending on the general public administration.
The researchers took the set of hospitalizations of individuals older than 75 years for coronary heart assaults, strokes or pulmonary embolisms between December 2020 and March 2021 and made a comparability between the vaccinated and the unvaccinated.
In keeping with the examine, the frequency of those episodes between one group and one other “didn’t differ considerably.”
Its authors plan to proceed monitoring the out there knowledge “to measure these dangers in individuals with a historical past of heart problems, in youthful populations and in sufferers vaccinated with different anticovid vaccines.”
France started its vaccination marketing campaign on the finish of December 2020, initially focusing solely on the aged, who have been basically receiving the drug from the Pfizer / BioNTech laboratory.
In Might, a examine by the identical group, primarily based basically on knowledge from this immunizer, established that vaccination decreased the chance of extreme types of COVID-19 by 87% in individuals older than 75 years seven days after the second dose. .